MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
stock under the...
$240K
Net cash provided by
financing activities
$163K
Canceled cashflow
$77K
Net decrease in cash
and cash...
-$51,711K
Canceled cashflow
$163K
Share-based compensation
expense
$11,633K
Depreciation and
amortization
$447K
Amortization of right-of-use
asset - operating
$383K
Prepaid and other assets
-$289K
Other long-term
liabilities
$12K
Loss on disposal of
property and equipment
-$6K
Interest income
$3,441K
Payment of reverse
recapitalization transaction...
$40K
Payment of issuance
costs associated with...
$37K
Net cash used in
operating activities
-$51,828K
Canceled cashflow
$12,770K
Net cash (used in)
provided by investing...
-$46K
Adjustments and reconciling
items
$3,441K
Net loss
-$59,517K
Canceled cashflow
$3,441K
Accounts payable,
accrued and other...
-$4,545K
Lease liabilities
-$536K
Purchases of property and
equipment
$46K
Direct program expense
$28,373K
Workforce salaries and
benefits
$16,301K
Share-based compensation
expense
$11,633K
General corporate
expenses
$4,720K
Indirect program expense
$1,923K
Interest and other
expense
$8K
Back
Back
Cash Flow
source: myfinsight.com
OnKure Therapeutics, Inc. (OKUR)
OnKure Therapeutics, Inc. (OKUR)